Skip to main content

Find Clinical Trials

Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,074 public trials 2,040 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

LTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or Pembrolizumab

NCT01986426

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +23 more
Locations: Jules Bordet Institute Brussels, Belgium

Cliniques Universitaires St-Luc, Service d'oncologie médicale Brussels, Belgium

Institut Curie Paris, France

Institute Gustave Roussy Paris, France

View all 14 locations

View Trial Details

Completed

Everolimus (RAD001) in Primary Therapy of Waldenstrom's Macroglobulinemia

NCT00976248

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Long-term Outcome of AIDS-related Primary Central Nervous System Lymphoma Treated With High Dose Methotrexate and Combined Antiretroviral Therapy

NCT03690895

Conditions: AIDS Related Lymphoma, Central Nervous System Lymphoma, Hemic and Lymphatic Diseases, +10 more
Locations: Fondation Ophtalmologique A. de Rotchschild Paris, France

View Trial Details

Completed

Glucarpidase Effect on Severe Delayed HDM-clearance in Children Treated With High-dose Mtx in ALL

NCT01305655

Conditions: Acute Lymphoblastic Leukemia (ALL), Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Department of Pediatrics, Rigshospitalet Copenhagen, Denmark

Helsinki University Hospital Helsinki, Finland

University of Reykjavik Reykjavik, Iceland

University Hospital of Trondheim Trondheim, Norway

View Trial Details

Completed

Safety and Efficacy of BKM120 in Relapsed and Refractory NHL

NCT01693614

Conditions: Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

University of Nebraska Medical Center Univ Nebraska Omaha, Nebraska, United States

Memorial Sloan Kettering Dept of Onc. New York, United States

Medical University of South Carolina -Hollings Cancer Center Medical Univ of South Carolina Charleston, South Carolina, United States

View all 20 locations

View Trial Details

Completed

Indenoisoquinoline LMP400 for Advanced Solid Tumors and Lymphomas

NCT01794104

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers

NCT00001873

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +36 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Experimental Bone Marrow Transplant Protocol

NCT00061581

Conditions: Acute Lymphocytic Leukemia, Acute Myelocytic Leukemia, Bone Marrow Diseases, +27 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves - PII B

NCT02184442

Conditions: Aortic Valve Disease, Aortic Valve Stenosis, Aortic Valve, Calcification of, +17 more
Locations: Arkansas Heart Hospital/Clinic Little Rock, Arkansas, United States

Scripps Green Hospital La Jolla, California, United States

Scripps Memorial Hospital La Jolla, California, United States

Cedars-Sinai Medical Center Los Angeles, California, United States

View all 53 locations

View Trial Details

Completed

Use of Zarzio® in Post-autologous Stem Cell Transplantation Procedure

NCT03323541

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
Locations: Not specified

View Trial Details